| Literature DB >> 35052520 |
Félix López de Felipe1, Blanca de Las Rivas1, Rosario Muñoz1.
Abstract
Lactobacilli are well-studied bacteria that can undergo oxidative selective pressures by plant phenolic compounds (PPCs) in plants, during some food fermentations or in the gastrointestinal tract of animals via dietary inputs. Lactobacilli are known to be more tolerant to PPCs than other bacterial groups and, therefore, must have mechanisms to cope with the effects of these metabolites. In this review, we intend to present what is currently known about the basics beyond the responses of Lactobacillus spp. to individual PPCs. We review the molecular mechanisms that are engaged in the PPC-modulated responses studied to date in these bacteria that have been mainly characterized by system-based strategies, and we discuss their differences and similarities. A wide variety of mechanisms are induced to increase the oxidative stress response highlighting the antimicrobial nature of PPCs. However other uncovered mechanisms that are involved in the response to these compounds are reviewed, including the capacity of PPCs to modulate the expression of molecular functions used by lactobacilli to adapt to host environments. This shows that these phytochemicals can act as more than just antimicrobial agents in the dual interaction with lactobacilli.Entities:
Keywords: Lactobacillus; molecular responses; plant phenolic compounds; system-based approaches
Year: 2021 PMID: 35052520 PMCID: PMC8772861 DOI: 10.3390/antiox11010018
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Figure 1Venn diagram assembled from Lactiplantibacillus plantarum WCFS1 genes differentially expressed in response to various plant phenolic compounds: p-coumaric acid (p-CA), resveratrol (RSV), hydroxytyrosol (HXT), and oleuropein (OLE).
Genes and proteins of Lactiplantibacillus plantarum WCFS1 induced by plant phenolic compounds that are responsive to oxidative stress.
| Phenolic Compound | Molecular Mechanism and Actors Involved | References | ||
|---|---|---|---|---|
| Enzymatic Inactivation of O2 Radicals | Repair of O2 Radical-Induced Damage | Modulation of Metal Transport Participating in the Fenton-Like Chemistry | ||
| Tannic acid | Npr2 | RecA | [ | |
| [ | ||||
| Resveratrol |
| [ | ||
| Oleuropein |
|
| [ | |
| Hydroxytyrosol |
|
| [ | |
Black font: upregulated genes or proteins. Red font: downregulated genes.
Figure 2Venn diagram assembled from Lactiplantibacillus plantarum WCFS1 general stress-related genes differentially upregulated in response to individual plant phenolic compounds. p-CA, p-coumaric acid; RSV, resveratrol; OLE, oleuropein; HXT, hydroxytyrosol.
Drug efflux and ABC transport systems of Lactiplantibacillus plantarum WCFS1 differentially expressed in presence of plant phenolic compounds.
| Phenolic Compound | Transporter Type | Locus Tags a and Fold Change b,c | References | |||
|---|---|---|---|---|---|---|
| ABC (BceAB-like) | ||||||
|
|
| |||||
| GA | −7.2 | −6.7 | [ | |||
| −6.4 | 2.0 | [ | ||||
| RSV | −12.4 | −2.7 | [ | |||
| OLE | −20.4 | −16.6 | [ | |||
| HXT | −4.7 | −3.8 | [ | |||
| MFS | ||||||
|
|
|
|
| |||
| 3.0 | 19.5 | 17.5 | 16.7 | [ | ||
| RSV | 5.8 | 5.6 | 5.5 | 5.7 | [ | |
| LmRA-like | ||||||
|
|
|
| ||||
| 10.2 | 8.7 | 9.8 | [ | |||
| RSV | 3.8 | 4.6 | 6.5 | [ | ||
a Designated gene number for the annotated L. plantarum WCFS1 genome; b fold change refers to growth in MRS supplemented with the corresponding PPC relative to growth in MRS without supplement; c FDR ≤ 0.05; p < 0.05.
Figure 3Venn diagram assembled from Lactiplantibacillus plantarum WCFS1 GlnR regulon genes involved in nitrogen metabolism that are differentially downregulated in response to individual plant phenolic compounds. p-CA, p-coumaric acid; RSV, resveratrol; HXT, hydroxytyrosol; GA, gallic acid.
Genes and proteins of Lactiplantibacillus plantarum WCFS1 associated with improved survival against gastrointestinal tract-induced stress that are differentially expressed by plant phenolic compounds.
| Locus Tags | PPC Effector (Ref.) a | Effect | Phenotype Involved | |
|---|---|---|---|---|
|
| ||||
|
| + | In vitro OGI survival [ | ||
|
| + | In vitro OGI survival | ||
|
| + | In vitro OGI survival | ||
|
|
| + | ||
|
| + | In vitro OGI survival | ||
|
| + | In vitro OGI survival | ||
|
| + | In vitro OGI survival | ||
|
| + | In vitro OGI survival | ||
|
| + | In vitro OGI survival | ||
|
| + | In vitro OGI survival | ||
|
| ||||
|
| HXT | + | Bile resistance [ | |
|
| + | Bile resistance | ||
|
| HXT, OLE | + | Bile resistance | |
|
| HXT, OLE | + | Bile resistance | |
|
| HXT, OLE | + | Bile resistance | |
|
| ||||
|
| cell surface protein precursor, LPXTG-motif cell-wall anchor | TA [ | + | Human/mouse GIT passage [ |
|
| TA [ | + | Human/mouse GIT passage [ | |
|
| TA [ | + | Mouse GIT passage [ | |
|
| TA [ | + | Mouse GIT passage [ | |
| PBP2A | transpeptidase–transglycosylase (penicillin binding protein 2A) | TA [ | - | GIT-robustness [ |
|
| + | Maintenance in gut ecosystems [ | ||
|
| HXT, | + | Maintenance in gut ecosystems [ | |
|
| OLE, | + | Maintenance in gut ecosystems [ | |
|
| multidrug transport protein, major facilitator superfamily (MFS) | + | Human small intestine passage [ | |
|
| + | Human small intestine passage [ | ||
|
| + | Human small intestine passage [ | ||
|
| + | Human small intestine passage [ | ||
|
| ||||
|
| ||||
| NADH-peroxidase | + | Resistance against oxidative stress at mucosal surface of the colon (putative) [ | ||
|
| ||||
| LDH-D | TA [ | + | Maintaining integrity of the cell envelope under GIT stress (bile, osmotic and acid stresses) (putative) [ | |
| DAPF | diaminopimelate (DAP) epimerase | TA [ | + | |
| GLMU | UDP- | Rutin [ | + | |
|
| + | |||
|
| + | |||
|
| lytic transglycosylases | + | ||
|
| ||||
|
| glycine betaine/carnitine/choline transport protein | − | Osmoprotection against osmotic stress in the GIT (putative) [ | |
a Reference describing the regulation of the molecular actor (gene or protein) by the plant phenolic compound. p-CA (p-coumaric acid), RSV (resveratrol), OLE (oleuropein), HXT (hydroxytyrosol), TA (tannic acid); b reference describing the phenotype associated with the molecular actor (gene or protein); +, upregulation; −, downregulation.
Genes and proteins of Lactobacillus involved in the interaction with host cells that are differentially expressed by plant phenolic compounds.
| Locus Tags | Species | PPC Effector (Ref.) a | Effect | Phenotype Involved | |
|---|---|---|---|---|---|
|
| |||||
|
|
| − | Reduced SPS levels [ | ||
|
| − | Reduced SPS levels | |||
|
| − | Reduced SPS levels | |||
|
| RSV [ | − | Reduced SPS levels | ||
|
| OLE [ | − | Reduced SPS levels | ||
|
| OLE | − | Reduced SPS levels | ||
|
| OLE | − | Reduced SPS levels | ||
|
| OLE | − | Reduced SPS levels | ||
|
| OLE | − | Reduced SPS levels | ||
|
| |||||
|
|
| HXT [ | + | Glycosyl substitution of WTA [ | |
| TagE6 | Poly(glycerol-phosphate) alpha-glucosyltransferase | TA [ | + | Glycosyl substitution of WTA [ | |
|
| OLE | + | Synthesis of alternative WTA variants [ | ||
|
| OLE | + | Synthesis of alternative WTA variants [ | ||
|
| OLE, HXT | + | Synthesis of alternative WTA variants [ | ||
|
| HXT | − | LTA glycosylation [ | ||
|
| |||||
| EF-P | Elongation factor EF-P |
| RSV [ | + | Adhesion [ |
| PK | Pyruvate kinase | RSV 109 | + | Adhesion [ | |
| EF-Tu | Elongation factor EF-Tu | RSV [ | + | Adhesion [ | |
| EF-P | Elongation factor EF-P | Caffeic acid [ | − | Adhesion [ | |
| PYK | Pyruvate kinase | Caffeic acid [ | − | Adhesion [ | |
| EF-Tu | Elongation factor EF-Tu | Caffeic acid [ | − | Adhesion [ | |
|
|
| + | Adhesion [ | ||
| EF-GreA | Elongation factor EF-GreA |
| TA [ | + | Adhesion [ |
| LuxS | Autoinducer production protein LuxS | TA [ | − | Adhesion [ | |
|
|
| RSV [ | + | Mannose-specific adhesion [ | |
|
| + | Adhesion [ | |||
|
| + | Adhesion [ | |||
|
| + | Adhesion [ | |||
|
| |||||
|
|
| OLE | − | Immunomodulatory capacity [ | |
|
| OLE | − | Immunomodulatory capacity [ | ||
|
| OLE | − | Immunomodulatory capacity [ | ||
|
| OLE | Immunomodulatory capacity [ | |||
|
| OLE | Immunomodulatory capacity [ | |||
|
| OLE | − | Immunomodulatory capacity [ | ||
|
| OLE | − | Immunomodulatory capacity [ | ||
|
| OLE | − | Immunomodulatory capacity [ | ||
|
| OLE | − | Immunomodulatory capacity [ | ||
|
| OLE | − | Immunomodulatory capacity [ | ||
|
| prophage P2b protein 21 | OLE | − | Immunomodulatory capacity [ | |
a Reference describing the regulation of the molecular actor (gene or protein) by the plant phenolic compound. p-CA (p-coumaric acid), RSV (resveratrol), OLE (oleuropein), HXT (hydroxytyrosol), TA (tannic acid); b reference describing the phenotype associated with the molecular actor (gene or protein); +, upregulation; −, downregulation.
Structural formulas of plant phenolic compounds and techniques used to study the molecular responses of Lactobacillus spp. to these compounds.
| Phenolic Compound | Technique | Species | References |
|---|---|---|---|
|
| |||
|
| Transcriptomics |
| [ |
|
| Transcriptomics |
| [ |
|
| Proteomics |
| [ |
|
| |||
|
| Transcriptomics |
| [ |
|
| |||
|
| Transcriptomics |
| [ |
|
| |||
|
| Transcriptomics |
| [ |
|
| |||
|
| Proteomics |
| [ |
|
| |||
|
| Transcriptomics |
| [ |
|
| |||
|
| Proteomics |
| [ |